Martin Shkreli probably didn’t expect to become the face of high prescription drug costs when he started the week. The hedge fund manager and founder of Turing Pharmaceuticals got national flack for obtaining the rights to manufacture old, life-saving medications such as a 62-year-old drug called Daraprim (used to treat patients with toxoplamosis, malaria, some cancers and AIDS) and raising the prices dramatic amounts. For example, Daraprim went from $13.50 to $750 per pill, a 5,500% increase. While he has backtracked and agreed to reduce the price, prescription drug costs are now back in the national conversation. Hillary Clinton and Bernie Sanders each announced proposals to lower costs. Do you think the government should do something about prescription drug costs?
THE NEWS MAY BE FAKE BUT THE DEBATES ARE REAL